Nataliya Pyslar, MD
Cardiovascular Disease · Park Ridge, ILNPI 1033352703
Payments from drug & device makers
Across 36 payments — averaging $1731.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$55K
- Regeneron$6K
- Novartis$266
- Regeneron Healthcare Solutions, Inc.$251
- Medicure Pharma Inc.$153
- Esperion Therapeutics, Inc.$149
- plus $222 from 3 others
What the payments were for
- Consulting fees$3,25263%
- Food & beverage$1,91437%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 13 | $55,111 |
| Regeneron | 4 | $6,166 |
| Novartis | 4 | $266 |
| Regeneron Healthcare Solutions, Inc. | 4 | $251 |
| Medicure Pharma Inc. | 1 | $153 |
| Esperion Therapeutics, Inc. | 4 | $149 |
| Sanofi-aventis U.S. LLC | 1 | $115 |
| Abbott | 4 | $80 |
| Boston Scientific | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVKEEZA$3,366
- Repatha$668
- ZYPITAMAG (pitavastatin)$153
- NO PRODUCT DISCUSSED$115
How this compares
$62,318 in reported general payments places this provider in the 85th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 49 | $29,473 |
| Praluent PenAlirocumab | 22 | $14,960 |
| Ezetimibe | 61 | $1,681 |
| Metoprolol Succinate | 47 | $1,018 |
| Rosuvastatin Calcium | 36 | $895 |
| Nifedipine ErNifedipine | 14 | $400 |
| Atorvastatin Calcium | 35 | $287 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 24 | $127 |
| Furosemide | 22 | $115 |
| Spironolactone | 12 | $68 |
| Carvedilol | 14 | $58 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Park Ridge
- Benjamin LumicaoChicago$3.7M
- Paul CremerChicago$2.9M
- Lokesh ChandraHazel Crest$2.7M
- Steven LupovitchArlington Heights$2.6M
- Nitasha SarswatChicago$2M
- Alan BrownNaperville$1.5M
- Alexander AdlerPeoria$1.5M
- Clifford KavinskyMaywood$1.4M
- Sanjiv ShahChicago$1.2M
- Sandeep NathanChicago$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.